GLPHubglpresearchhub.com
Read-only archive. GLP Research Hub is a static community record — nothing here is for sale, no account is needed, and no vote you cast is counted. Why?
Single comment threadYou are looking at one branch of genuine question about ATTAIN that I am slightly embarrassed to ask — 50 comments in the full submission. View in context.
2.6k
c/orforglipron·submitted 1 year ago by u/adaeze_cabrera

genuine question about ATTAIN that I am slightly embarrassed to ask

Questionbranch of 6 comments

Confession thread, sort of. I went from 12.5mg to 5mg much faster than I should have because the scale had stalled and I got impatient. The stall broke about 11 weeks later, at which point I had no way of knowing whether the dose increase did anything or whether it would have broken anyway. So now I have…

Read the full submission and all 50 comments →

This branch

6 comments, started 1 year ago
u/graph_it_gary204 points·1 year ago

Respectfully this is a sample of one presented as a finding.

replysharereportpermalink
u/lukas_delgado272 points·1 year ago

This is correct. ATTAIN data is phase 11.

replysharereportpermalink
u/zeynep_ndiaye-3 points·1 year ago

the supply conversation changes if this approves

replysharereportpermalink
u/flair_enthusiast1 point·1 year ago

the supply conversation changes if this approves

Adding to this: oral GLP-1 is doing more work than the comment implies.

replysharereportpermalink
u/yara_boateng1 point·1 year ago

This is correct. ATTAIN data is phase 8.

replysharereportpermalink
u/laila_delgado1 point·1 year ago

Did anything else change in the same window?

replysharereportpermalink

← back to the whole thread

About c/orforglipron

The small-molecule oral: why a non-peptide agonist escapes the absorption problems of oral semaglutide, what the ATTAIN and ACHIEVE readouts showed, and what a pill with no refrigeration requirement would do to the entire supply conversation this site is built around.

21kmembers
62submissions
Feb 2024created
submissions / month, last year
Sponsored

Sigma-Aldrich Standards

Certified reference materials for peptide identity and purity work.

sigmaaldrich.com
More in c/orforglipron
c/orforglipron rules
  1. Small molecule, not a peptide. Purity discussion here is a different problem.
  2. Cite ATTAIN/ACHIEVE arms specifically when quoting numbers.
  3. Availability speculation must be flaired Speculation.
  4. Independent community. Nobody here sells anything, and anyone who tries is banned.
  5. Not medical advice. Describe what you did; never prescribe to a stranger.
  6. Claims need evidence. Batch numbers, dated screenshots, independent test reports, or a citation.
  7. No referral links, discount codes or affiliate URLs. Permanent ban, no appeal.
  8. No contact handles, wallet addresses or tracking numbers — they identify people.
  9. Be recognisably decent. Disagree hard, insult nobody.
Full rules and how they are enforced →
Moderators
u/incretin_ivyu/phase_two_peteu/trialwatch_theo
Volunteers. Unpaid, unaffiliated, and reachable through modmail only.
Before you read on

Several compounds discussed on GLP Research Hub are sold for research use only and are not approved for human use anywhere. Nothing here is medical advice and none of it is written by your clinician. If a post reads like an instruction, treat it as a description of what one stranger did.

Full disclaimer →